Lobbying client

SAFETYSPECT

Biotechnology research, development, and manufacturing company.

Filings
11
Filed by
1
Reported in-house
—
Reported by firms
$150,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2024 to 2026

Filings

5 filings for 2024, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2024
FORBES-TATE $20,000 reported
3rd Quarter - Report
3rd Quarter 2024
FORBES-TATE $20,000 reported
2nd Quarter - Report
2nd Quarter 2024
FORBES-TATE $20,000 reported
1st Quarter - Report
1st Quarter 2024
FORBES-TATE — reported
Registration
1st Quarter 2024
FORBES-TATE — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
FORBES-TATE 10 $150,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 4120 118th 28
S. 1979 118th 28
S. 2703 119th 21
H.R. 5115 119th 14
S. 1979 119th 7
H.R. 4120 119th 7

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.